This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
February 07, 2018
Q4 2017 General Market Overview
February 06, 2018
Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
February 01, 2018
BONESUPPORTTM repays outstanding loan from Kreos
February 01, 2018
2017 ANNUAL RESULTS AND UPDATE ON TANGO
February 01, 2018
Nordic Nanovector Appoints Malene Brondberg as Vice President, Investor Relations and Corporate Communications
January 25, 2018
GenSight Biologics reports €55 million 2017 year-end cash position and provides corporate update
January 25, 2018
Cash position and activity update for Q4 2017
January 25, 2018
Onxeo receives EPO Intent-to-Grant Notice for key AsiDNA™ patent, extending IP protection in Europe until 2031
January 25, 2018
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
January 23, 2018
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.